Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hasle, Henrik  [Clear All Filters]
2024
Kløve-Mogensen K, Haunstrup TMors, Masmas TNicole, Glenthøj A, Höglund P, Hasle H, Nielsen KRené, Steffensen R. High-resolution HLA genotyping identifies risk alleles in both class I and II for primary autoimmune neutropenia in early childhood in a Danish cohort. HLA. 2024;103(3):e15429.
Tierens A, Arad-Cohen N, Cheuk D, de Moerloose B, Navarro JMaria Fern, Hasle H, Jahnukainen K, Juul-Dam KLøvvik, Kaspers G, Kovalova Z, et al. Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease. J Clin Oncol. 2024:JCO2301841.
van Weelderen RElise, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, et al. Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia. Blood Adv. 2024.
2023
Rubio-San-Simón A, van Eijkelenburg NKA, Hoogendijk R, Hasle H, Niemeyer CM, Dworzak MN, Zecca M, Lopez-Yurda M, Janssen JM, Huitema ADR, et al. Azacitidine (Vidaza) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015). Paediatr Drugs. 2023.
Karlsson L, Cheuk D, de Moerloose B, Hasle H, Jahnukainen K, Juul-Dam KLøvvik, Kaspers G, Kovalova Z, Lausen B, Nyström UNorén, et al. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia. Br J Haematol. 2023.
Förster A, Davenport C, Duployez N, Erlacher M, Ferster A, Fitzgibbon J, Göhring G, Hasle H, Jongmans MC, Kolenova A, et al. European standard clinical practice - Key issues for the medical care of individuals with familial leukemia. Eur J Med Genet. 2023:104727.
Kløve-Mogensen K, Steffensen R, Masmas TNicole, Glenthøj A, Jensen CFriis, Haunstrup TMors, Ratcliffe P, Höglund P, Hasle H, Nielsen KRené. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort. Int J Immunogenet. 2023.
van Weelderen RE, Klein K, Harrison CJ, Jiang Y, Abrahamsson J, Arad-Cohen N, Bart-Delabesse E, Buldini B, de Moerloose B, Dworzak MN, et al. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group. J Clin Oncol. 2023:JCO2202120.
Raghuram N, Nakashima K, Rahman SAb, Antoniou E, Skajaa T, Merli P, Verma A, Rabin KR, Aftandilian C, Kotecha RSury, et al. Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome. Blood Adv. 2023.
Mark C, Meshinchi S, Joyce B, Gibson B, Harrison C, Bergmann AK, Goemans BF, Pronk CJan H, Lapillonne H, Leverger G, et al. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias. Br J Haematol. 2023.
2022
Petersen MA, Rosenberg CA, Brøndum RF, Aggerholm A, Kjeldsen E, Rahbek O, Ludvigsen M, Hasle H, Roug AS, Bill M. Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups. Br J Haematol. 2022.
2021
Asdahl PH, Oeffinger KC, Albieri V, Hudson M, Leisenring WM, Donaldson SS, Hasle H, Winther JF, Armstrong GT, Robison LL. Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study. Pediatr Blood Cancer. 2021:e29043.
Hasle H, Kline RM, Kjeldsen E, Nik-Abdul-Rashid NF, Bhojwani D, Verboon JM, DiTroia SP, Chao KR, Raaschou-Jensen K, Palle J, et al. Germline GATA1s generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype. Blood. 2021.
Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, Noellke P, Dworzak M, Stary J, Locatelli F, et al. Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med. 2021.
2015
Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, et al. Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents. Blood. 2015.
2013
Yoshimi A, van den Heuvel-Eibrink MM, Baumann I, Schwarz S, Simonitsch-Klupp I, de Paepe P, Campr V, Kerndrup GBirk, Sullivan MO', Devito R, et al. Comparison of horse and rabbit anti-thymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica. 2013.
Niinimäki R, Hansen LMølgaard, Niinimäki T, Olsen JH, Pokka T, Sankila R, Vettenranta K, Hasle H, Harila-Saari A. Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and Denmark. J Adolesc Young Adult Oncol. 2013;2(4):138-144.